EUVIMEDEUVIMED entdecken
Crossref

Neoadjuvant chemoradiotherapy followed by oesophagectomy may be the optimal treatment option for lower thoracic oesophageal cancer with supraclavicular lymph node metastasis: An inverse probability of treatment‐weighted analysis of SEER database

Xiao Chang iD, Jiayue Liu, Yuting Zhao, Anhui Shi, Huiming Yu, Rong Yu, Weihu Wang iD

Journal of Medical Imaging and Radiation Oncology · 2023-09 · 67 (6) · 676-683

DOI: 10.1111/1754-9485.13561 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Imaging and Radiation Oncology, online erschienen am 14.07.2023. Verfasst von Xiao Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Canc…. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Esophageal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: the Beijing Municipal Science & Technology Commission, Beijing Hospitals Authority's Ascent Plan, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Whether supraclavicular lymph node (SCLN) metastasis in patients with oesophageal cancer belongs to regional disease is controversial, leading to heterogeneity in clinical treatment decisions. This study aimed to determine the optimal treatment for lower thoracic oesophageal cancer (LTOC) with SCLN metastasis.

Methods

Patients with LTOC registered in the Surveillance, Epidemiology, and End Results database during 2010–2015 were identified. Selected patients were grouped according to disease spread as those with locoregional disease, with SCLN metastasis or with distant metastasis, as well as according to treatment modality (neoadjuvant chemoradiotherapy followed by surgery (nCRT+S group), upfront surgery ± adjuvant therapy (upfront S group) and definitive chemoradiotherapy (dCRT group)). The Cox regression analysis and inverse probability of treatment weighting (IPTW) were used to identify the optimal treatment modality for different groups.

Results

Of 11,767 LTOC patients identified from the database, the 5‐year overall survival (OS) rates for patients with the locoregional disease ( n = 7,541), SCLN metastasis ( n = 120) and distant metastasis ( n = 4,106) were 28.3%, 10.0% and 3.0%, respectively ( P < 0.001). Among patients with SCLN metastasis, median OS in the nCRT+S, upfront S and dCRT groups were 25, 14 and 8 months, respectively ( P < 0.001). After IPTW, the nCRT+S group was still associated with better median OS compared with other groups. The multivariate analysis identified treatment modality as an independent prognostic factor for OS.

Conclusions

Neoadjuvant chemoradiotherapy followed by oesophagectomy may be the optimal treatment modality for LTOC with SCLN metastasis. The findings of this study need to be validated in large prospective studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyEsophageal NeoplasmsHumansLymphatic MetastasisEsophagectomyProspective StudiesLymph NodesChemoradiotherapyProbabilityRetrospective StudiesNeoplasm Staging

Stichwörter der Autor:innen

clinical and cost benefitgastro intestinalradiation oncology

Autor:innen und Institutionen

  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, China.

ORCID-Profile: Xiao Chang, Weihu Wang

Förderung

  • the Beijing Municipal Science & Technology Commission
  • Beijing Hospitals Authority's Ascent Plan
  • National Natural Science Foundation of China

Zitieren

APA

Chang, X., Liu, J., Zhao, Y., Shi, A., Yu, H., Yu, R., & Wang, W. (2023). Neoadjuvant chemoradiotherapy followed by oesophagectomy may be the optimal treatment option for lower thoracic oesophageal cancer with supraclavicular lymph node metastasis: An inverse probability of treatment‐weighted analysis of SEER database. Journal of Medical Imaging and Radiation Oncology, 67(6), 676-683. https://doi.org/10.1111/1754-9485.13561

Vancouver

Chang X, Liu J, Zhao Y, Shi A, Yu H, Yu R, et al. Neoadjuvant chemoradiotherapy followed by oesophagectomy may be the optimal treatment option for lower thoracic oesophageal cancer with supraclavicular lymph node metastasis: An inverse probability of treatment‐weighted analysis of SEER database. Journal of Medical Imaging and Radiation Oncology. 2023;67(6):676-683. doi:10.1111/1754-9485.13561

BibTeX
@article{Chang2023,
  author = {Chang, Xiao and Liu, Jiayue and Zhao, Yuting and Shi, Anhui and Yu, Huiming and Yu, Rong and Wang, Weihu},
  title = {Neoadjuvant chemoradiotherapy followed by oesophagectomy may be the optimal treatment option for lower thoracic oesophageal cancer with supraclavicular lymph node metastasis: An inverse probability of treatment‐weighted analysis of SEER database},
  journal = {Journal of Medical Imaging and Radiation Oncology},
  year = {2023},
  volume = {67},
  number = {6},
  pages = {676--683},
  doi = {10.1111/1754-9485.13561}
}
Kostenlos starten →